Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 37 - Drugs for immunological or allergic disorders
Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
10/1991
10/31/1991WO1991016437A1 Soluble peptide analogues containing binding sites
10/31/1991WO1991016430A1 NOVEL T-CELL LYMPHOMA cDNA CLONES
10/31/1991WO1991016347A1 Composition for macrophage activation
10/31/1991WO1991016303A1 Cyclic hydroxamic acids and their use
10/31/1991WO1991016048A1 2(5H)-FURANONES SUBSTITUTED IN THE 3 POSITION, AS Ca2+ CHANNEL ANTAGONISTS AND ANTI-INFLAMMATORY AGENTS
10/31/1991CA2081207A1 Soluble peptide analogues containing binding sites
10/31/1991CA2040551A1 Deoxymacrolide derivatives having immunosuppressive activity
10/30/1991EP0454429A2 Use of 15-dehydroxy-16-oxoprostaglandin derivatives in the treatment of allergic diseases
10/30/1991EP0454102A2 Essential fatty acid compositions
10/30/1991EP0454060A1 3-(Mercaptoalkyl)-quinazoline-2,4(1H,3H)-diones, processes for their preparation, and pharmaceutical compositions
10/30/1991EP0453497A1 Treatment methods and vaccines
10/30/1991CN1055732A Novel alpha-mannosidase and fucosidase inhibitors
10/29/1991US5061787 Novel spergualin-related compounds and compositions
10/29/1991US5061728 Use of 4-phenyl-1,2,3,4-tetrahydro-1-naphthalenamine derivatives in the treatment of inflammation and as immunosuppressants
10/29/1991US5061718 Benzothiazolylmethoxy compounds, pharmaceutical compositions comprising the same and their use as anti-inflammatory or anti-allergenic agents
10/25/1991WO1991016431A1 Soluble, truncated gamma-interferon receptors
10/25/1991CA2081309A1 Soluble, truncated gamma-interferon receptors
10/24/1991WO1991016345A1 Cyclic peptides and their use
10/24/1991CA2081312A1 Cyclic peptides and their use
10/23/1991EP0452908A2 Lipoxygenase-inhibiting compounds derived from non-steroidal antiinflammatory carboxylic acids
10/23/1991EP0452873A1 1,8-Naphthyridin-2-one derivatives
10/23/1991EP0452847A2 Use of a hypoallergenic wheat preparation for preparing a processed food for a person afflicted with food allergies to wheat
10/23/1991EP0452433A1 Cytolysis inhibitor proteins (cli) and dna sequences coding for said proteins
10/22/1991US5059712 Isolating aminoarginine and use to block nitric oxide formation in body
10/22/1991US5059611 Anti-inflammatory 5-hydroxy-2-furanones
10/22/1991US5059610 Treatment of hypersensitive disorders; antiinflammatory, antiallergic agents
10/22/1991US5059596 Azabicyclo compounds
10/22/1991US5059537 Acellular vaccine
10/21/1991WO1991016298A1 Antiinflammatory hydroxamic acids and n-hydroxyureas
10/21/1991CA2078216A1 Antiinflammatory hydroxamic acids and n-hydroxyureas
10/20/1991CA2040608A1 Lipoxygenase-inhibiting compounds derived from non-steroidal antiinflammatory carboxylic acids
10/19/1991WO1991017187A2 A 35kD TUMOR ASSOCIATED PROTEIN ANTIGEN: USES AND METHODS OF DETECTION
10/19/1991CA2080835A1 A 35kd tumor associated protein antigen and immune complex
10/18/1991CA2078770A1 2(5h)-furanones substituted in the 3 position, as ca2+ channel antagonists and anti-inflammatory agents
10/17/1991WO1991015475A1 Novel vitamin d analogues
10/17/1991WO1991015225A1 Multiple sclerosis t-cell receptor
10/17/1991WO1991015221A1 Inhibition of allograft and concordant xenograft rejection
10/17/1991WO1991008298A3 Fusion proteins consisting of a ligand binding protein and a stable plasma protein
10/17/1991WO1991006537A3 Substituted indole-, indene-, pyranoindole- and tetrahydrocarbazole- alkanoic acid derivatives as inhibitors of pla2 and lipoxygenase
10/17/1991CA2029857A1 Sustained-release preparation composition comprising pyridazinone compound
10/16/1991EP0451834A2 Alpha-mannosidase and fucosidase inhibitors
10/16/1991EP0451634A2 Cycloalkano[b]dihydroindoles and -indolesulphonamides substituted by heterocycles
10/16/1991EP0451439A1 Use of a cartilage-inducing factor (CIF) for treating hematopoietic or lymphopoietic disorders
10/16/1991EP0451299A1 Magnetocontrollable carrier with physiologically active substance and method for making said carrier
10/16/1991EP0434744A4 Serum immunoregulatory polypeptide and uses therefor
10/16/1991EP0423193A4 A method of treating diseases caused by immunodeficiency states by administering human neutrophil chemotactic factor to human
10/16/1991CN1014323B Method for extracting physiological active substances from pine-nut shell
10/15/1991US5057614 Substituted pyrroles
10/15/1991US5057530 Glycerol derivatives
10/15/1991US5057526 Pharmaceutically active pyridinyl substituted 5,7-dihydropyrrolo-[3,2-f]benzoxazole-6-ones
10/15/1991US5057513 Spiro-thiazepine derivatives useful as paf antagonists
10/15/1991US5057423 Method for the preparation of pure LAK-active lymphocytes
10/15/1991US5057324 Kallikrein inhibitor substance, a process for preparation and pharmaceutical compositions thereof
10/15/1991US5057322 Method of treating mast cell disease
10/14/1991CA2080002A1 Composition for macrophage activation
10/11/1991CA2039955A1 Pharmaceutical compounds
10/11/1991CA2039873A1 Cycloalkano(b)dihydroindoles and -indolesulphonamides substituted by heterocycles
10/10/1991WO1992017583A1 Isolated viral protein cytokine antagonists
10/10/1991WO1991015503A1 T-cell suppressor protein
10/10/1991CA2080371A1 T-cell suppressor protein
10/09/1991EP0450792A2 Glomerellan as an immunostimulant and/or an anti-tumor agent
10/09/1991EP0450095A1 Method of assaying d-vanillylmandelic acid, and reagent and kit therefor
10/09/1991EP0449915A1 New tnf peptides
10/09/1991EP0449828A1 HUMAN Fc$g(g) RECEPTOR III
10/09/1991EP0207124B1 Use of podophyllotoxin and derivatives thereof
10/09/1991CN1055116A Method for producting pharmaceutical composition containing il-4 as active ingredient
10/09/1991CN1055110A Pharmaceutical solution
10/08/1991US5055452 Skin disorders
10/08/1991US5055447 Administering transforming growth factor beta
10/08/1991CA1290335C Pharmaceutical compounds
10/08/1991CA1290248C Treatment of infections with lymphokines
10/03/1991WO1991014450A1 Use of il-4 to enhance immune response to infectious antigenic challenges
10/03/1991WO1991014449A1 Induction of protection against viral infection
10/03/1991WO1991014434A1 Multi-functional pharmaceutical compounds and methods of use
10/03/1991WO1991010735A3 Human receptor of tsh. sequence coding for such receptor
10/03/1991CA2078676A1 Use of il-4 to enhance immune response to infectious antigenic challenges
10/03/1991CA2057040A1 Induction of protection against viral infection by synergy between virus envelope glycoprotein and peptides corresponding to neutralization epitopes of the glycoprotein
10/02/1991EP0449769A1 CD 25 binding molecules
10/02/1991CN1054981A Therapeutic nucleosides
10/01/1991WO1991015223A1 Respiratory burst suppression factor
10/01/1991US5053547 Benzonorbornene derivatives, processes for their preparation and medicinal and cosmetic compositions containing them
10/01/1991US5053419 Administering calcium channel antagonists
10/01/1991CA2055593A1 Respiratory burst suppression factor
10/01/1991CA1289954C Xanthine derivatives
10/01/1991CA1289952C N-(2-aminoacylamido-2-deoxy-hexosyl)-amides, -carbamates and -ureas, processes for their preparation, and their use in medicaments
09/1991
09/28/1991WO1991014674A2 5-lipoxygenase inhibitors
09/28/1991WO1991014432A1 Supportive use
09/28/1991CA2078126A1 5-lipoxygenase inhibitors
09/25/1991EP0448181A2 Interleukin-6 inhibiting compositions
09/25/1991EP0448099A2 Novel peptides
09/25/1991EP0447857A1 A polycyclic compound, method for preparing the same, and pharmaceutical composition comprising the same
09/25/1991EP0447476A1 New tnf peptides
09/25/1991EP0447474A1 New tnf peptides
09/25/1991EP0447472A1 New tnf peptides
09/25/1991EP0447465A1 New tnf peptides
09/25/1991EP0447435A1 Novel tnf peptides
09/25/1991EP0447432A1 New tnf peptides
09/25/1991EP0447431A1 New tnf peptides
09/25/1991EP0447430A1 New tnf peptides
09/25/1991EP0447429A1 New tnf peptides
1 ... 1114 1115 1116 1117 1118 1119 1120 1121 1122 1123 1124 1125 1126 1127 1128 1129 1130 1131 1132 1133 1134 ... 1172